Literature DB >> 9572535

Lactoferrin suppresses loss of corneal epithelial integrity in a rabbit short-term dry eye model.

T Fujihara1, T Nagano, M Nakamura, E Shirasawa.   

Abstract

Human tear fluid contains lactoferrin at the highest concentration. In patients with dry eye such as Sjogren's syndrome, the concentration of lactoferrin in the tears is approximately half the normal value. The present study utilizes a short-term rabbit dry eye model to evaluate if lactoferrin containing eye drops can reverse any of the damage produced by blockage of blinking with an ocular speculum. Damage was evaluated based on the extent of methylene blue staining in histological sections. After 3 h of desiccation, the amount of extractable dye recovered following sacrifice increased by more than 4-fold in the vehicle-treated eyes. However, in those rabbits treated with 1% lactoferrin, dye recovery was only 40% of the value in the vehicle-treated eyes. Between 1-3 h and over a concentration range from 0.01 to 1% lactoferrin, the decreases in staining were both time and concentration dependent. Alternatively, if 1% lactoferrin was applied during the desiccation period, there was partial restoration of corneal epithelial integrity. These results suggest that lactoferrin may be of therapeutic value in decreasing the loss of corneal epithelial integrity in dry eye.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9572535     DOI: 10.1089/jop.1998.14.99

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  9 in total

Review 1.  Iron homeostasis and eye disease.

Authors:  Allison Loh; Majda Hadziahmetovic; Joshua L Dunaief
Journal:  Biochim Biophys Acta       Date:  2008-11-14

Review 2.  Age-related Defects in Ocular and Nasal Mucosal Immune System and the Immunopathology of Dry Eye Disease.

Authors:  Marjan Farid; Anshu Agrawal; Daniel Fremgen; Jeremiah Tao; He Chuyi; Anthony B Nesburn; Lbachir BenMohamed
Journal:  Ocul Immunol Inflamm       Date:  2014-12-23       Impact factor: 3.070

3.  Dietary lactoferrin alleviates age-related lacrimal gland dysfunction in mice.

Authors:  Motoko Kawashima; Tetsuya Kawakita; Takaaki Inaba; Naoko Okada; Masataka Ito; Shigeto Shimmura; Mitsuhiro Watanabe; Ken Shinmura; Kazuo Tsubota
Journal:  PLoS One       Date:  2012-03-27       Impact factor: 3.240

4.  Anti-inflammatory effects of rebamipide eyedrop administration on ocular lesions in a murine model of primary Sjögren's syndrome.

Authors:  Rieko Arakaki; Hiroshi Eguchi; Akiko Yamada; Yasusei Kudo; Akihiko Iwasa; Tserennadmid Enkhmaa; Fumika Hotta; Sayaka Mitamura-Aizawa; Yoshinori Mitamura; Yoshio Hayashi; Naozumi Ishimaru
Journal:  PLoS One       Date:  2014-05-27       Impact factor: 3.240

5.  Selenium-binding lactoferrin is taken into corneal epithelial cells by a receptor and prevents corneal damage in dry eye model animals.

Authors:  Akihiro Higuchi; Hiroyoshi Inoue; Yoshio Kaneko; Erina Oonishi; Kazuo Tsubota
Journal:  Sci Rep       Date:  2016-11-11       Impact factor: 4.379

Review 6.  Lactoferrin and its nano-formulations in rare eye diseases.

Authors:  Jiya Singh; Mohita Sharma; Neha Jain; Insha Aftab; Naval Vikram; Tej P Singh; Pradeep Sharma; Sujata Sharma
Journal:  Indian J Ophthalmol       Date:  2022-07       Impact factor: 2.969

7.  Selenium compound protects corneal epithelium against oxidative stress.

Authors:  Akihiro Higuchi; Hiroyoshi Inoue; Tetsuya Kawakita; Tadashi Ogishima; Kazuo Tsubota
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

Review 8.  Practical issues concerning tear protein assays in dry eye.

Authors:  Sharon D'Souza; Louis Tong
Journal:  Eye Vis (Lond)       Date:  2014-11-13

Review 9.  Therapeutic Effects of Lactoferrin in Ocular Diseases: From Dry Eye Disease to Infections.

Authors:  Aldo Vagge; Carlotta Senni; Federico Bernabei; Marco Pellegrini; Vincenzo Scorcia; Carlo E Traverso; Giuseppe Giannaccare
Journal:  Int J Mol Sci       Date:  2020-09-12       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.